Cognitive effects of darifenacin and oxybutynin extended release in volunteers aged 60 and over
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2007
At a glance
- Drugs Darifenacin; Oxybutynin
- Indications Overactive bladder
- Focus Pharmacodynamics
- Sponsors Novartis
- 12 Jul 2007 Status changed from in progress to completed.
- 10 Dec 2005 New trial record.